---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-018460"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2026-04-22T23:59:59+00:00"
generated_at: "2026-05-15T04:51:44.518490+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Daré Bioscience posts updated corporate presentation on investor website

## Summary
- Presentation dated April 22, 2026, furnished as Exhibit 99.1.
- No material financial or operational updates specified in the 8-K body.
- Presentation content not provided; confidence in news value is low.

## SEC filing metadata
- accession: 0001493152-26-018460
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2026-04-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315226018460/0001493152-26-018460-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315226018460/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-018460
- JSON: https://secwatch.observer/filing/0001493152-26-018460.json
- Plain text: https://secwatch.observer/filing/0001493152-26-018460.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.